Announcing an exciting talk by an expert from Agilent, a partner for the C-CAMP Biologics Characterisation and Mass Spectrometry facilities on the current onco immunotherapy buzzword - CART-Cell, the discovery to product journey.
Talk Topic: Advanced Analytics for Assessment of Chimeric Antigen Receptor T-Cell from Discovery to Development & Manufacturing
Date & Time: Thursday, 7th August; 10:00 to 10:45 AM
Venue: Chausa, C-CAMP
About the speaker: Dr. Fei Chuin, Head of Agilent Market Development for the Asia-Pacific region.
Speaker Biography - She possesses a Master’s degree in Immunology from the National University of Singapore. Her professional journey began in academic research for 11 years, where she investigated biomarkers in Asian lupus patients by flow cytometry to potentially allow individualized therapy to reduce Systemic Lupus Erythematosus severe manifestations with the National University of Singapore, in collaboration with National University Hospital and University of Cambridge UK. During her tenure at over the past eight years, she has excelled as a leader in the regional cell analysis business, driving significant growth and cultivating strategic partnerships that have been instrumental to the company’s success. Among her most distinguished accomplishments was her pivotal role in spearheading a strategic collaboration in the field of cell and gene therapy (CGT). In 2023, she successfully secured a landmark Memorandum of Understanding (MOU) with ACTRIS (Advanced Cell Therapy and Research Institute, Singapore), a testament to her exceptional ability to forge impactful partnerships and drive innovation across the region.
